Insider Buying: CVS Group (LON:CVSG) Insider Buys £20,489.04 in Stock

CVS Group plc (LON:CVSGGet Free Report) insider Joanne Shaw bought 1,592 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were purchased at an average price of GBX 1,287 per share, with a total value of £20,489.04.

CVS Group Stock Up 0.8%

LON:CVSG traded up GBX 10.10 during trading hours on Tuesday, hitting GBX 1,300.10. The company’s stock had a trading volume of 129,076 shares, compared to its average volume of 950,214. The stock has a market capitalization of £889.83 million, a P/E ratio of 18.87, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The stock has a fifty day moving average of GBX 1,235.13 and a 200-day moving average of GBX 1,241.15. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34. CVS Group plc has a 52-week low of GBX 1,062 and a 52-week high of GBX 1,648.

CVS Group announced that its Board of Directors has initiated a share buyback program on Tuesday, May 26th that allows the company to buyback 0 shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Jefferies Financial Group increased their price objective on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a report on Friday, July 31st. Berenberg Bank restated a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a research note on Thursday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,700 price target on shares of CVS Group in a report on Monday, July 27th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 1,720.

Check Out Our Latest Stock Analysis on CVSG

About CVS Group

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

Further Reading

Insider Buying and Selling by Quarter for CVS Group (LON:CVSG)

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.